Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

Share Price is delayed by 15 minutes
Get Live Data
330.20    -5.20 (-1.55%)
Bid:
328.60
Ask:
330.20
Spread: 1.60 (0.487%)
Market Cap: £723.37m
BUR Live PriceLast checked at - London Stock Exchange

Intraday Burford Capital Share Chart

Final Results

18 Mar 2015 07:01

RNS Number : 7134H
Burford Capital
18 March 2015
 

18 March 2015

 

BURFORD CAPITAL DELIVERS 43% GROWTH IN 2014 OPERATING PROFIT

 

34% increase in dividend proposed

 

Burford Capital Limited ("Burford" or "the Company"), the world's largest provider of investment capital and risk solutions for litigation,announces its financial results for the full year ended 31 December 2014.

 

Highlights

 

· 43% increase in Burford's operating profit for 2014 to $60.7 million (2013: $42.5 million)*, representing a 17% return on equity

 

· 34% dividend increase proposed, to 7.00¢ per share (2013: 5.23¢), composed of 1.74¢ interim dividend paid in December 2014 and final dividend of 5.26¢ to be paid in June 2015

 

· 35% increase in Burford's income for the year, to $82.0 million (2013: $60.7 million):

 

o 23% increase in income from the litigation investment portfolio amid continuing increases in activity levels;

 

o 16% increase in insurance income reflecting strong performance of the historical book

 

· Continued strong investment returns: Since inception, 32 investments have generated $209 million in gross investment recoveries** and $78 million net of invested capital, producing a 60% net return on invested capital

 

o This represents a 56% increase in net investment recoveries over the position at 31 December 2013 and a significant increase in net ROIC from its prior 52% level

 

· Material increase in cash generation: Burford generated $63 million of cash from the investment portfolio in 2014, an increase of 98% over 2013's level

 

· Robust demand for Burford's capital reflected in $150 million of new investment commitments in 2014, more than three times 2013's level

 

· Completion of a successful issue of retail bonds on the main market of the London Stock Exchange, raising $150 million (£90 million) of capital to be deployed in litigation finance activities

 

 

*Excluding the accounting impact of the Burford UK acquisition, the 2012 Reorganisation and 2013 UK Restructuring.

** See definitions in Note 3 of Annual Report.

 

 

Christopher Bogart, Chief Executive Officer of Burford, commented: 

"We are very pleased with 2014's results. It was an excellent year for Burford with growth in revenue and profits across all areas of the Company. As Burford enters its sixth year, we have continued to generate strong investment returns and continue to see growing, evolving and diversifying demand for the litigation finance solutions we provide."

 

Sir Peter Middleton, Chairman of Burford, commented:

"We are pleased to report another successful year of significant growth and progress for Burford. As a result, the Board recommends a 34% increase in the dividend. We are proud to have assembled what is clearly the leading and most experienced team in the litigation finance industry and we look forward to our future progress in this rapidly evolving sector. "

 

 

Financial Summary

 

A financial summary is set out below. Burford's complete annual report and audited accounts are attached in PDF form to this RNS and are available from the Burford website: www.burfordcapital.com

 

The figures for taxation and profit after tax exclude the impact of the Burford UK acquisition, the 2012 Reorganisation and the one-off 2013 UK Restructuring and are shown to assist in understanding the underlying performance of the Company. All other figures presented are derived directly from the audited consolidated financial statements.

 

2014

2013

% change

$'000

$'000

Litigation investment income

47,847

38,847

23%

Insurance income

24,338

20,910

16%

New initiatives income

222

-

Other income

9,627

903

Total income

82,034

60,660

35%

Operating expenses - litigation investment

(10,416)

(9,005)

Operating expenses - insurance

(5,396)

(6,779)

Operating expenses - new initiatives

(1,561)

-

Operating expenses - corporate

(3,950)

(2,362)

Operating profit

60,711

42,514

43%

Finance costs

(3,652)

-

Profit before tax and the impacts relating to the Burford UK acquisition, the 2012 Reorganisation and 2013 UK Restructuring costs

57,059

42,514

34%

Taxation*

(2,906)

(2,276)

Profit after tax**

54,153

40,238

35%

 

* Taxation does not include deferred taxation credit on amortisation of embedded value intangible asset.

** This is profit after tax excluding the impact of the Burford UK acquisition, the 2012 Reorganisation, and 2013 UK Restructuring.

 

 

Investor and Analyst Conference Call

 

Burford will host a conference call for investors and analysts at 11:30am (GMT) / 7:30am (EDT) on Wednesday 18 March 2015. The dial-in number for the conference call is 0800 376 7922 / 1 (866) 966-1396 and the passcode is 97542914.

 

An accompanying presentation will be available on the Investor Relations page of the Burford website: www.burfordcapital.com/investor-relations/ 

 

A replay facility will be available until 25 March 2015. The dial-in number for the replay facility is 0800 953 1533 / 1 (866) 247-4222 and the passcode is 97542914.

 

 

Click on, or paste the following link into your web browser, to view the associated PDF document.

http://www.rns-pdf.londonstockexchange.com/rns/7134H_-2015-3-17.pdf

 

 

For further information, please contact:

 

Macquarie Capital (Europe) Limited - NOMAD and Joint Broker

Ken Fleming +44 (0)20 3037 2000

Nicholas Harland

 

Espirito Santo Investment Bank - Joint Broker

John Riddell +44 (0)20 7456 9191

Harry Stockdale

 

RBC Capital Markets - Joint Broker

Oliver Hearsey +44 (0)20 7653 4000

 

Neustria Partners - Financial Communications for Burford Capital

Robert Bailhache +44 (0)20 3021 2580

robert.bailhache@neustriapartners.com

 

 

About Burford Capital

 

Burford Capital is the world's largest provider of investment capital and risk solutions for litigation with the largest and most experienced dedicated team in the industry. Burford is publicly traded on the London Stock Exchange's AIM market under the ticker symbol BUR. Burford provides a broad range of corporate finance and insurance solutions to lawyers and clients engaged in significant litigation and arbitration around the world.

 

For more information about Burford, visit www.burfordcapital.com

 

 

-------------------------------------------

 

Sir Peter Middleton, Chairman of Burford, has informed the Company that Hume Capital Securities plc, another firm as to which he serves as Chairman, has been placed into administration and he will no longer serve as a director thereof.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR GGUPWWUPAGRM
Date   Source Headline
1st Jul 20255:46 pmRNSUS Budget Bill Adopted Without Lit Fin Provisions
1st Jul 20257:15 amRNSUpdate Re US Budget Bill and YPF Ruling
30th Jun 20258:00 amRNSFurther Statement Re US Budget Reconciliation Bill
30th Jun 20257:00 amRNSChange of Nominated Adviser
17th Jun 20257:00 amRNSStatement Re US Budget Reconciliation Bill
10th Jun 20251:00 pmRNSIssue of Equity & Director/PDMR Shareholding
6th Jun 202511:30 amRNSCompleted Purchases of Shares
5th Jun 20251:00 pmRNSIntended Purchases of Ordinary Shares
30th May 202512:00 pmRNSSterling FX Rate for 2024 Final Dividend
16th May 20251:30 pmRNSDirector/PDMR Shareholding
15th May 20251:00 pmRNSResult of AGM
14th May 202512:37 pmRNSMSCI Change to BUR Index Country Classification
7th May 20251:00 pmRNS1Q25 Financial Results
6th May 202512:00 pmRNSNotice of Retail Shareholder Audio Webcast
30th Apr 202512:00 pmRNSNotice of 1Q25 Results & Results Call Details
28th Apr 202512:00 pmRNSAdditional Definitive Proxy Soliciting Materials
10th Apr 202512:00 pmRNSIssue of Equity & Director/PDMR Shareholding
4th Apr 20257:00 amRNSDefinitive Proxy Materials and 2024 Annual Report
3rd Apr 202512:00 pmRNSStrategic Update at 2025 Investor Day
17th Mar 202511:00 amRNSPartial Repurchase and Cancellation of Bonds
17th Mar 202511:00 amRNSIntended Purchases of Ordinary Shares
11th Mar 20257:30 amRNSDirector/PDMR Shareholding
4th Mar 20257:00 amRNSFiling of 2024 Annual Report on Form 10-K
3rd Mar 202512:00 pmRNSAnnual Results for Year Ended December 31, 2024
25th Feb 20257:00 amRNSNotice of 2024 Results & Reporting Change Preview
4th Feb 20252:00 pmRNSBurford Capital announces 2025 Investor Day
31st Jan 20257:30 amRNSDirector/PDMR Shareholding
27th Dec 202411:00 amRNSIssue of New Shares in Connection With LTIP
17th Dec 202411:00 amRNSDirector/PDMR Shareholding
22nd Nov 202412:00 pmRNSDirector/PDMR Shareholding
15th Nov 20241:15 pmRNSPartial Repurchase and Cancellation of Bonds
8th Nov 202412:00 pmRNSSterling Conversion Rate for 2024 Interim Dividend
7th Nov 202412:46 pmRNS3Q24 Results & Quarterly Report
7th Nov 202412:03 pmRNSBurford Statement re YPF Matter
28th Oct 202412:00 pmRNSNotice of 3Q24 Results & Results Call Details
17th Oct 202411:00 amRNS2025 AGM Logistics
1st Oct 202411:00 amRNSDirector/PDMR Shareholding
25th Sep 20241:15 pmRNSIssue of New Shares in Connection With LTIP
23rd Aug 202412:00 pmRNSResult of Meeting
23rd Aug 202411:30 amRNSDirector/PDMR Shareholding
21st Aug 202411:00 amRNSDirector/PDMR Shareholding
8th Aug 202412:00 pmRNS2Q24 Results & Quarterly Report
5th Aug 202412:00 pmRNSTransition to US Domestic Issuer Status
31st Jul 202412:00 pmRNSNotice of 2Q24 Results & Results Call Details
22nd Jul 202412:00 pmRNSNotice of EGM
10th Jul 20247:00 amRNSAppointment of KPMG LLP as Independent Auditor
2nd Jul 202411:00 amRNSHolding(s) in Company
28th Jun 202412:00 pmRNSIssue of New Shares for LTIP & Adjusted PDMR LTIP
21st Jun 20241:00 pmRNSIssue of New Shares Pursuant to DCP & PDMR Notices
6th Jun 20241:30 pmRNSPartial Repurchase and Cancellation of Bonds

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.